Service by

Home Journal Issues Instructions for Authors Editorial Board About Journal Aims & Scope


Original Research 
RMJ. 2016; 41(3): 339-341


Immunoprophylaxis in Rh Incompatibility

Sadia Fahim, Muntiha Sarosh, Nikhat Ahsan.

Abstract
Objective: To investigate the frequency of Rh–ive patients and effectiveness of Rh immunization, comparing antibody titer before and after immunization.
Methodology: This comparative cross sectional study was carried out at the Department of Obstetrics and Gynecology, Fatima Hospital, Baqai Medical University, Karachi, from January 2013 to June 2014. Fifty primigravid women with Rh –ve blood group and their husbands with Rh +ve blood group were included in the study. The antibody titer through indirect Coomb’s test was checked in all the patients at 28 weeks gestation. If –ve titers, AntiD 1500 IU for prophylaxis was given between 28-34 weeks. After delivery, if baby was Rh +ve, AntiD was given within 72 hrs. Antibody titer was again measured at 6 weeks postpartum.
Results: Out of 50 primigravidae, 68% were B –ve, 30% were A –ve and 2% were O –ve. At 28 wks, 78% showed 1:4 dilution, 22% showed 1:8 dilution and no one reached up to 1:16 dilution. Six weeks postnatally, when antibody titers were repeated, there was no significant increase in titer.
Conclusion: The antibody titers are independent of AntiD IgG and immunization did not affect the level of antibody titer. Anti D IgG is thus the only and most effective prophylaxis against the Rh incompatability disease.

Key words: Immunoprophylaxis, Anti D, Antibody titre, Rh incompatibility


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Export to
Export to
Related Records
 Articles by Sadia Fahim
Articles by Muntiha Sarosh
Articles by Nikhat Ahsan
on Google
on Google Scholar
Article Statistics
 Viewed: 997
Downloaded: 146
Cited: 0


How to Cite this Article
Pubmed Style

Fahim S, Sarosh M, Ahsan N. Immunoprophylaxis in Rh Incompatibility. RMJ. 2016; 41(3): 339-341.


Web Style

Fahim S, Sarosh M, Ahsan N. Immunoprophylaxis in Rh Incompatibility. http://www.rmj.org.pk/?mno=222112 [Access: September 18, 2018].


AMA (American Medical Association) Style

Fahim S, Sarosh M, Ahsan N. Immunoprophylaxis in Rh Incompatibility. RMJ. 2016; 41(3): 339-341.



Vancouver/ICMJE Style

Fahim S, Sarosh M, Ahsan N. Immunoprophylaxis in Rh Incompatibility. RMJ. (2016), [cited September 18, 2018]; 41(3): 339-341.



Harvard Style

Fahim, S., Sarosh, M. & Ahsan, N. (2016) Immunoprophylaxis in Rh Incompatibility. RMJ, 41 (3), 339-341.



Turabian Style

Fahim, Sadia, Muntiha Sarosh, and Nikhat Ahsan. 2016. Immunoprophylaxis in Rh Incompatibility. Rawal Medical Journal, 41 (3), 339-341.



Chicago Style

Fahim, Sadia, Muntiha Sarosh, and Nikhat Ahsan. "Immunoprophylaxis in Rh Incompatibility." Rawal Medical Journal 41 (2016), 339-341.



MLA (The Modern Language Association) Style

Fahim, Sadia, Muntiha Sarosh, and Nikhat Ahsan. "Immunoprophylaxis in Rh Incompatibility." Rawal Medical Journal 41.3 (2016), 339-341. Print.



APA (American Psychological Association) Style

Fahim, S., Sarosh, M. & Ahsan, N. (2016) Immunoprophylaxis in Rh Incompatibility. Rawal Medical Journal, 41 (3), 339-341.




Instructions for Authors

AUTHOR LOGIN

REVIEWER LOGIN

Indexed In

WHO Index Medicus IMEMR,
Emromedex,
Pakmedinet,
ExtraMED and
Scopus

Approved by the Higher Education Commission of Pakistan and Pakistan Medical and Dental Council



The articles in Rawal Medical Journal are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.